Insmed Incorporated
INSM
$189.70
$4.022.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -67.79% | -7.01% | -63.33% | -26.60% | -38.75% |
| Total Depreciation and Amortization | 58.25% | 48.43% | 12.73% | 0.14% | -1.53% |
| Total Amortization of Deferred Charges | -5.30% | -4.12% | -0.95% | -0.13% | -11.63% |
| Total Other Non-Cash Items | 158.35% | -24.41% | 140.91% | -85.19% | 22.18% |
| Change in Net Operating Assets | 188.34% | -75.89% | -19.88% | 266.65% | 34.37% |
| Cash from Operations | -21.47% | -67.19% | -42.41% | -49.81% | -32.70% |
| Capital Expenditure | 34.45% | 48.64% | -115.22% | -214.54% | -29.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.00% | -- | -69.84% | 3,401.77% | -10,096.82% |
| Cash from Investing | 24.04% | 3,458.91% | -72.77% | 7,207.71% | -14,140.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.53% | -318.14% | -13.69% | -158.83% | 39.74% |
| Issuance of Common Stock | -91.41% | 10.08% | 633.07% | -88.76% | 16,895.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.59% | 9.77% | 859.56% | 29.24% | 31,701.44% |
| Foreign Exchange rate Adjustments | -153.07% | 246.08% | 193.91% | -248.42% | -15.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.91% | 35.33% | -233.90% | 2,074.66% | -524.44% |